Related Experiment Video
Updated: Mar 30, 2026

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
An amyloid-like cascade hypothesis for C9orf72 ALS/FTD
Dieter Edbauer1, Christian Haass2
1German Center for Neurodegenerative Diseases (DZNE), Munich, Feodor-Lynen-Str. 17, 81377 Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Feodor-Lynen-Str. 17, 81377 Munich, Germany; Ludwig-Maximilians University Munich, 81377 Munich, Germany.
Expansion of GGGGCC repeats in C9orf72 causes neurodegenerative diseases like ALS and FTD. Both repeat RNA and dipeptide repeat proteins drive toxicity by disrupting cellular transport and promoting TDP-43 aggregation.
Area of Science:
- Neurobiology
- Genetics
- Molecular Biology
Background:
- C9orf72 GGGGCC repeat expansion is a leading genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
- Pathogenic mechanisms involve repeat RNA transcripts and their translation into toxic dipeptide repeat (DPR) proteins.
Purpose of the Study:
- To elucidate the molecular cascade initiated by C9orf72 repeat expansion.
- To understand the roles of repeat RNA and DPRs in neurodegeneration and TDP-43 pathology.
Main Methods:
- Analysis of repeat RNA and DPR protein interactions.
- Investigation of effects on cellular transport and protein aggregation.
- Comparison with Alzheimer's disease pathogenesis.
Main Results:
- Bidirectional repeat transcripts form nuclear RNA foci, sequestering RNA-binding proteins.
- DPR proteins inhibit proteasomal function and sequester other cellular proteins.
- Both repeat RNA and DPRs impair nucleocytoplasmic transport and induce TDP-43 mislocalization and aggregation.
- These molecular events precede brain atrophy and cognitive impairment.
Conclusions:
- The C9orf72 repeat expansion triggers a cascade involving repeat RNA and DPRs, leading to TDP-43 pathology and neurodegeneration.
- This cascade shares similarities with amyloid-β peptide-induced pathology in Alzheimer's disease.
- Targeting components of the C9orf72 cascade offers potential therapeutic strategies for ALS and FTD.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils

